MedPath

Comparison between TAPENTADOL and PREGABALIN for preventing catheter related bladder discomfort.

Phase 4
Conditions
Health Condition 1: N401- Benign prostatic hyperplasia withlower urinary tract symptoms
Registration Number
CTRI/2024/07/070516
Lead Sponsor
Sri Ramachandra Institute of Higher Education and Research
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
ot Yet Recruiting
Sex
Not specified
Target Recruitment
0
Inclusion Criteria

Male

Age 18 to 80 years

ASA I , II , III

Undergoing Elective Transurethral resection of Prostate under Regional anaesthesia

Requiring bladder catheterization

Exclusion Criteria

ASA IV patients

Contraindication for spinal anaesthesia

Significant cardiac disease

Chronic analgesic use

High AV Block

Psychiatric disease

Renal failure

Paralytic ileus

History of urinary tract obstruction/neurogenic/ overactive bladder

Acute exacerbation of Bronchial Asthma

Study & Design

Study Type
Interventional
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
To assess the incidence of postoperative Catheter Related Bladder Discomfort.Timepoint: 0 minutes <br/ ><br>30 minutes <br/ ><br>1st hour <br/ ><br>2nd hour <br/ ><br>4th hour <br/ ><br>8th hour <br/ ><br>12th hour <br/ ><br>24th hour
Secondary Outcome Measures
NameTimeMethod
eed for additional analgesic. <br/ ><br>Assess any adverse effects including postoperative nausea and vomiting, respiratory depression, sedation, drowsiness, confusion and dry mouth.Timepoint: 0 minutes <br/ ><br>30 minutes <br/ ><br>1st hour <br/ ><br>2nd hour <br/ ><br>4th hour <br/ ><br>8th hour <br/ ><br>12th hour <br/ ><br>24th hour
© Copyright 2025. All Rights Reserved by MedPath